SCHEDULE 13DAccepted Sep 26, 6:45 PM ET
CASI Pharmaceuticals, Inc. SCHEDULE 13D
Accepted (ET)
6:45 PM
Sep 26, 2025
Filed
Sep 26, 2025
Documents
2
Size
143.2 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.